SCI Pharmtech Inc (4119) — Working Capital to Net Assets Ratio
SCI Pharmtech Inc (4119) has a Working Capital to Net Assets ratio of 1.0% as of December 2025. Working capital of NT$54.05 Million (current assets of NT$1.09 Billion minus current liabilities of NT$1.04 Billion) is measured against net assets of NT$5.39 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of SCI Pharmtech Inc to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SCI Pharmtech Inc Working Capital to Net Assets (2009–2025)
This chart shows how SCI Pharmtech Inc's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of December 2025, the ratio stands at 1.0%, reflecting working capital of NT$54.05 Million against net assets of NT$5.39 Billion TWD. Check 4119 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for SCI Pharmtech Inc (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SCI Pharmtech Inc from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see SCI Pharmtech Inc market capitalisation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1.0% | NT$54.05 Million | NT$5.39 Billion | NT$1.09 Billion | NT$1.04 Billion | ▼ -10.8 pp |
| 2024 | 11.8% | NT$646.01 Million | NT$5.48 Billion | NT$1.66 Billion | NT$1.01 Billion | ▼ -15.3 pp |
| 2023 | 27.1% | NT$1.38 Billion | NT$5.10 Billion | NT$1.95 Billion | NT$569.89 Million | ▲ +19.6 pp |
| 2022 | 7.5% | NT$272.08 Million | NT$3.63 Billion | NT$1.04 Billion | NT$770.32 Million | ▼ -12.1 pp |
| 2021 | 19.6% | NT$649.37 Million | NT$3.32 Billion | NT$1.40 Billion | NT$747.94 Million | ▼ -4.4 pp |
| 2020 | 24.0% | NT$796.60 Million | NT$3.32 Billion | NT$1.92 Billion | NT$1.12 Billion | ▼ -14.9 pp |
| 2019 | 38.9% | NT$1.35 Billion | NT$3.47 Billion | NT$1.94 Billion | NT$584.26 Million | ▲ +3.1 pp |
| 2018 | 35.8% | NT$1.15 Billion | NT$3.21 Billion | NT$1.71 Billion | NT$556.71 Million | ▲ +1.8 pp |
| 2017 | 34.0% | NT$995.81 Million | NT$2.93 Billion | NT$1.34 Billion | NT$342.97 Million | ▼ -4.0 pp |
| 2016 | 38.0% | NT$1.17 Billion | NT$3.07 Billion | NT$1.62 Billion | NT$455.40 Million | ▲ +6.8 pp |
| 2015 | 31.3% | NT$863.33 Million | NT$2.76 Billion | NT$1.54 Billion | NT$672.91 Million | ▼ -10.7 pp |
| 2014 | 41.9% | NT$933.33 Million | NT$2.23 Billion | NT$1.33 Billion | NT$396.56 Million | ▼ -6.2 pp |
| 2013 | 48.1% | NT$995.58 Million | NT$2.07 Billion | NT$1.39 Billion | NT$391.43 Million | ▲ +26.9 pp |
| 2012 | 21.2% | NT$267.82 Million | NT$1.26 Billion | NT$571.73 Million | NT$303.92 Million | ▲ +2.7 pp |
| 2011 | 18.6% | NT$209.90 Million | NT$1.13 Billion | NT$582.17 Million | NT$372.27 Million | ▲ +3.4 pp |
| 2010 | 15.1% | NT$171.02 Million | NT$1.13 Billion | NT$536.10 Million | NT$365.08 Million | ▼ -12.5 pp |
| 2009 | 27.6% | NT$286.32 Million | NT$1.04 Billion | NT$495.02 Million | NT$208.71 Million | — |